The aim of this study is to investigate the antimicrobial susceptibility of strains isolated from the major hospitals in China. A total of 44 teaching hospitals were involved. Antimicrobial susceptibility testing was conducted by Kirby-Bauer automated systems, and results were interpreted using CLSI criteria. Totally 244,843 strains were isolated in 2018, of which gram-negative bacilli and gram-positive cocci were accounting for 71.8% and 28.2%, respectively. 39.7% of isolates were cultured from lower respiratory tract, 18.8% from urine, 14.8% from blood, 1.3% from cerebrospinal fluid, respectively. Of those, the five major species were most often isolated (65.5%, 63%, 52.3%, and 30.3%). The resistance rate of MRSA to most antimicrobial agents was significantly higher than that of MSSA strains, except for to trimethoprim-sulfamethoxazole in urine specimen. E.coli was still highly susceptible to carbapenem antibiotics, and the resistance rate was less than 5%. Carbapenem resistance among Klebsiella pneumoniae, especially cultured from cerebrospinal fluid, increased significance from 18.6 to 64.1%. The resistance rates of Pseudomonas aeruginosa to carbapenems were nearly 30% in the blood, in urine, and in the lower respiratory tract, but about 60% of that in cerebrospinal fluid. About 80% of Acinetobacter baumannii strains was resistant to imipenem and meropenem, respectively. Bacterial resistance of five major clinical isolates from cerebrospinal fluid to common antibiotics (in particular Carbapenem-resistant Klebsiella pneumoniae) currently shows an increasing trend. It is worth to emphasize the importance of serious control of hospital infection and better management of clinical use of antimicrobial agents.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81871690]; Pfizer Investigator Initiated Research [WI 207259]
第一作者机构:[1]Fudan Univ, Huashan Hosp, Inst Antibiot, Shanghai, Peoples R China[2]Minist Hlth, Key Lab Clin Pharmacol Antibiot, Shanghai, Peoples R China
共同第一作者:
通讯作者:
通讯机构:[1]Fudan Univ, Huashan Hosp, Inst Antibiot, Shanghai, Peoples R China[2]Minist Hlth, Key Lab Clin Pharmacol Antibiot, Shanghai, Peoples R China
推荐引用方式(GB/T 7714):
Hu Fupin,Guo Yan,Yang Yang,et al.Resistance reported from China antimicrobial surveillance network (CHINET) in 2018[J].EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES.2019,38(12):2275-2281.doi:10.1007/s10096-019-03673-1.
APA:
Hu, Fupin,Guo, Yan,Yang, Yang,Zheng, Yonggui,Wu, Shi...&Yue, Chunlei.(2019).Resistance reported from China antimicrobial surveillance network (CHINET) in 2018.EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES,38,(12)
MLA:
Hu, Fupin,et al."Resistance reported from China antimicrobial surveillance network (CHINET) in 2018".EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 38..12(2019):2275-2281